Sidoti Csr Weighs in on Hawkins' Q1 Earnings (NASDAQ:HWKN)

Hawkins, Inc. (NASDAQ:HWKN - Free Report) - Stock analysts at Sidoti Csr lifted their Q1 2026 earnings per share estimates for shares of Hawkins in a research report issued on Friday, May 2nd. Sidoti Csr analyst D. Harriman now forecasts that the specialty chemicals company will post earnings per share of $1.35 for the quarter, up from their prior forecast of $1.30. The consensus estimate for Hawkins' current full-year earnings is $4.00 per share. Sidoti Csr also issued estimates for Hawkins' Q2 2026 earnings at $1.29 EPS, Q3 2026 earnings at $0.88 EPS, Q4 2026 earnings at $0.93 EPS, FY2026 earnings at $4.45 EPS, Q1 2027 earnings at $1.37 EPS, Q2 2027 earnings at $1.29 EPS, Q3 2027 earnings at $1.03 EPS, Q4 2027 earnings at $1.11 EPS and FY2027 earnings at $4.80 EPS.

A number of other research analysts have also recently commented on the company. BWS Financial upgraded Hawkins from a "neutral" rating to a "buy" rating and set a $160.00 price objective on the stock in a report on Monday, April 14th. CJS Securities started coverage on Hawkins in a report on Tuesday, April 1st. They set a "market outperform" rating and a $125.00 price target for the company.

Hawkins Trading Down 0.1 %

Shares of HWKN traded down $0.14 during mid-day trading on Monday, reaching $119.35. The stock had a trading volume of 86,312 shares, compared to its average volume of 123,868. The business's fifty day moving average is $111.77 and its 200 day moving average is $117.06. Hawkins has a 52-week low of $71.98 and a 52-week high of $139.55. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.50 and a quick ratio of 1.53. The firm has a market cap of $2.50 billion, a price-to-earnings ratio of 30.45, a P/E/G ratio of 3.80 and a beta of 0.87.

Institutional Trading of Hawkins

Several institutional investors have recently added to or reduced their stakes in the stock. Inspire Advisors LLC lifted its stake in Hawkins by 3.9% during the first quarter. Inspire Advisors LLC now owns 4,881 shares of the specialty chemicals company's stock worth $517,000 after purchasing an additional 182 shares in the last quarter. Royce & Associates LP lifted its stake in Hawkins by 8.3% during the 1st quarter. Royce & Associates LP now owns 114,812 shares of the specialty chemicals company's stock worth $12,161,000 after acquiring an additional 8,785 shares in the last quarter. GW&K Investment Management LLC boosted its holdings in Hawkins by 3.2% during the 1st quarter. GW&K Investment Management LLC now owns 220,327 shares of the specialty chemicals company's stock valued at $23,337,000 after acquiring an additional 6,832 shares during the period. Allianz Asset Management GmbH acquired a new position in Hawkins in the 1st quarter valued at about $244,000. Finally, Segall Bryant & Hamill LLC increased its stake in Hawkins by 33.8% during the first quarter. Segall Bryant & Hamill LLC now owns 63,829 shares of the specialty chemicals company's stock worth $6,761,000 after purchasing an additional 16,136 shares during the period. Institutional investors and hedge funds own 69.71% of the company's stock.

Hawkins Company Profile

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.